Which factor explains why topical medications can produce greater systemic absorption in infants than in adults?
Choose an answer, then check it.
Clinical Pharmacology · Special Populations
Pediatric Pharmacology
On this page 6 sections
In 30 seconds
A child is not a small adult, pharmacologically speaking. Absorption, distribution, metabolism, and excretion all change dramatically as a child grows, so a drug that behaves predictably in an adult can be erratic, toxic, or ineffective in a neonate, infant, or young child. Because children have almost no physiologic reserve to absorb an error, dosing must be individualized to weight or body surface area, verified by an independent double-check, and delivered with tools built for precision. Certain drugs are outright avoided in pediatrics because of documented, serious harms unique to developing bodies.
The college version
Why Development Changes Everything
Pharmacokinetics describes what the body does to a drug: absorb, distribute, metabolize, and excrete it. Every process depends on organs still maturing throughout childhood, so the same milligram-per-kilogram dose can produce very different blood levels in a newborn, a toddler, a school-age child, and an adolescent. Clinicians treat pediatrics as several distinct physiologic stages, not one uniform category, because a premature neonate and a teenager share almost nothing pharmacokinetically.
Absorption
Gastric pH is higher, or less acidic, in young infants than in adults, altering the breakdown and absorption of acid-sensitive oral drugs. Gastric emptying is slower and more irregular in early infancy, making time to peak concentration less predictable. Infant skin, especially in preterm neonates, is thinner and more permeable, and the surface-area-to-weight ratio is much higher than an adult's. Together this means topical medications and antiseptics absorb systemically to a much greater degree, raising toxicity risk from products considered merely "topical" in adults.
Distribution
Neonates and infants carry more total body water and less body fat than older children or adults. Water-soluble drugs distribute into a larger volume, lowering peak concentration but prolonging the drug's presence. Plasma protein binding is reduced in neonates because albumin is not yet mature, so more of a drug circulates unbound and active. This matters for bilirubin: certain drugs compete with it for albumin binding sites, displacing it into unbound circulation where it can cross into brain tissue and cause kernicterus, a bilirubin-induced brain injury. The neonatal blood-brain barrier is also more permeable, giving drugs greater central nervous system access than intended.
Metabolism
Hepatic enzyme systems, including cytochrome P450 pathways, are immature at birth and mature along different timelines per enzyme. This produces a nonlinear pattern across childhood: a newborn may metabolize a drug very slowly, creating accumulation risk, while a young child whose enzymes have matured, and can even temporarily exceed adult activity per kilogram, may clear the same drug unusually fast, requiring relatively higher per-kilogram dosing than an adult. This is a clear illustration of why pediatric dosing cannot simply be scaled down from an adult dose.
Excretion
Glomerular filtration is immature in neonates, particularly those born prematurely, so renally cleared drugs can accumulate to toxic levels unless dosing intervals are extended. Renal function matures over subsequent months, and intervals are adjusted as filtration capacity increases.
Dosing Precision and Safety Culture
Because pediatric patients have little to no physiologic reserve, a dosing error an adult might tolerate can be catastrophic in a child. Doses are calculated by weight or body surface area rather than flat adult doses, and an independent double-check by a second clinician is standard for high-risk pediatric medications. Decimal point errors and tenfold miscalculations are especially dangerous because the margin between therapeutic and toxic doses is often narrow, so small absolute errors become large relative overdoses. Oral liquids are preferred for children who cannot swallow tablets, with doses measured and communicated in milliliters using an oral syringe rather than a household spoon, since spoon sizes are inconsistent and imprecise. Certain excipients carry specific pediatric risk: benzyl alcohol, a preservative in some injectable and oral products, has been linked to serious neonatal toxicity and is avoided in that age group.
Pediatric-Specific Contraindications and Cautions
Several agents carry well-established pediatric warnings. Aspirin is avoided in children and adolescents with viral illness for its association with Reye syndrome, a rare but severe hepatic and neurologic condition. Tetracyclines can permanently discolor developing teeth. Fluoroquinolones carry a caution regarding effects on developing cartilage. Codeine and tramadol carry restrictions following certain surgeries, such as tonsillectomy, and additional danger in patients who are ultrarapid metabolizers of these prodrugs, converting them to their active opioid metabolite unusually quickly with risk of life-threatening respiratory depression. Promethazine carries a caution against use in young children due to respiratory depression risk. Over-the-counter cough and cold combination products are discouraged in young children given a poor risk-to-benefit profile and a history of serious adverse events without proven benefit at that age.
Practical and Family-Centered Considerations
Much pediatric drug therapy is used off-label, since many medications are studied primarily in adults; clinicians rely on accumulated pediatric experience and specialized references rather than official labeling alone. Adherence depends on palatability, formulation, and involving caregivers as partners in administration. Immunization is among the most consequential pediatric interventions and follows its own structured schedule and safety monitoring. Family-centered teaching includes safe medication storage, since a single adult-strength tablet of certain medications can be lethal to a small child, and caregivers must understand dosing devices, avoid confusing products sharing the same ingredient, and know when to seek emergency care.
Eli explains
The same idea, in plain words
Explain it like I’m 10
Imagine a brand-new car engine that hasn't been broken in yet, next to a big, powerful, fully broken-in truck engine. Pour the same fuel into both, and they won't run the same way — the new engine might flood or stall, while the truck engine handles it fine. A baby's body is like that new engine: the parts that break down medicine (the liver) and flush it out (the kidneys) aren't fully built yet, and they get better at different speeds for different jobs. A baby's skin is also thinner, like tissue paper compared to leather, so creams soak in more than on a grown-up. That's why doctors and nurses can't just give a "mini" adult dose — they figure out the exact amount for that specific kid's size, double-check the math with another person, and use a marked syringe instead of a kitchen spoon, because even a tiny mistake is a much bigger deal for a small body with no cushion to absorb it.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A caregiver plans to measure a child's liquid antibiotic using a kitchen teaspoon because that is what is available at home. Explain why this practice is discouraged in pediatric dosing.
Show answer
Kitchen spoons are not standardized.
Teaspoons vary in actual volume from spoon to spoon, so a "teaspoon" dose could be meaningfully more or less medicine than intended; an oral syringe measures exact milliliters, essential when a child has little room for a dosing error.
A nurse is asked to administer a pediatric dose that requires a decimal point in the calculation. Explain why an independent double-check is especially important here.
Show answer
Decimal errors can cause tenfold dosing mistakes.
A misplaced decimal point can turn a safe pediatric dose into ten times too much or too little, and because children have minimal physiologic reserve, a second clinician independently verifying the calculation catches an error before it reaches the child.
Quick check
3 questions here. Answers stay hidden until you check.
A drug that displaces bilirubin from albumin binding sites in a neonate raises concern for which complication?
Choose an answer, then check it.
Why can young children sometimes require a higher per-kilogram dose of a hepatically metabolized drug than an adult?
Choose an answer, then check it.
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.